<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335681">
  <stage>Registered</stage>
  <submitdate>20/03/2011</submitdate>
  <approvaldate>22/03/2011</approvaldate>
  <actrnumber>ACTRN12611000305921</actrnumber>
  <trial_identification>
    <studytitle>Measurements of central and peripheral refraction of the eye using a novel instrument, the EyeMapper.</studytitle>
    <scientifictitle>A prospective, single-group, open-labelled study to measure central and peripheral refraction in healthy volunteers with a novel instrument, the EyeMapper.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Central and peripheral refraction of the eye</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Normal eye development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Peripheral refraction instrument - mode of operation. 
Participants will be recruited over a period of 5 months. Participants will be asked to attend the clinic for up to five visits.  Each visit will take up to 1 hour. During these visits central and peripheral refraction measurements will be performed using up to three different instruments, the EyeMapper which is a novel peripheral refraction instrument, the Shin Nippon NVision K5001, a commercially available open view autorefractor and the COAS, a commercially available aberrometer.</interventions>
    <comparator>Central and peripheral refraction measured with a commercially available autorefractor, the Shin-Nippon NVision K5001, and a commercially available COAS aberrometer will be used as control measures. Both instruments have slightly been modified to enable the measurement of the peripheral optics of the eye.</comparator>
    <control>Active</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Central and peripheral refraction</outcome>
      <timepoint>Visit 1 (Baseline)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Instrument Preference Questionnaire</outcome>
      <timepoint>End of Visit 1</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Participants enrolled in the trial must be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent and must be at least 18 years old.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Participants enrolled in the trial must not been currently enrolled in another clinical trial and must not have manifest strabismus or any anterior eye anomalies.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Random sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/03/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Brien Holden Vision Institute</primarysponsorname>
    <primarysponsoraddress>Level 5, North Wing, Rupert Myers Building, Gate 14, Barker Street, UNSW Sydney NSW 2052</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>Brien Holden Vision Institute</fundingname>
      <fundingaddress>Level 5, North Wing, Rupert Myers Building, Gate 14, Barker Street, UNSW Sydney NSW 2052</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress>N/A</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Vision Cooperative Research Centre and Institute for Eye Research Human Ethics Committee</ethicname>
      <ethicaddress>Level 4, North Wing, Rupert Myers Building, Gate 14, Barker Street, UNSW Sydney NSW 2052</ethicaddress>
      <ethicapprovaldate>18/08/2010</ethicapprovaldate>
      <hrec>10/12/2011</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Cathleen Fedtke</name>
      <address>Level 5, North Wing, Rupert Myers Building, Gate 14, Barker Street, UNSW Sydney NSW 2052</address>
      <phone>+61 2 9385 7523</phone>
      <fax />
      <email>c.fedtke@brienholdenvision.org</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Cathleen Fedtke</name>
      <address>Level 5, North Wing, Rupert Myers Building, Gate 14, Barker Street, UNSW Sydney NSW 2052</address>
      <phone>+61 2 9385 7523</phone>
      <fax />
      <email>c.fedtke@brienholdenvision.org</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Cathleen Fedtke</name>
      <address>Level 5, North Wing, Rupert Myers Building, Gate 14, Barker Street, UNSW Sydney NSW 2052</address>
      <phone>+61 2 9385 7523</phone>
      <fax />
      <email>c.fedtke@brienholdenvision.org</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>